Warby Parker (WRBY) Non-Current Deffered Revenue (2020 - 2021)
Warby Parker posted quarterly Non-Current Deffered Revenue of $36.5 million for Q4 2021, up 30.53% year-on-year from $28.0 million in Q4 2020, and up 17.97% on a QoQ basis from $31.0 million in Q3 2021.
Warby Parker (WRBY) has 2 years of Non-Current Deffered Revenue data on file, last reported at $36.5 million in Q4 2021.
- For the quarter ending Q4 2021, Non-Current Deffered Revenue rose 30.53% year-over-year to $36.5 million; the trailing twelve-month figure through Dec 2021 stood at $36.5 million (up 30.53% YoY), and the FY2021 full-year result was $36.5 million, up 30.53% from the prior year.
- Non-Current Deffered Revenue for Q4 2021 stood at $36.5 million, up from $31.0 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $36.5 million in Q4 2021 and bottomed at $28.0 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 163.15 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 11.80 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 206.40 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | - |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | - |
| 10 | Warby Parker | 3.03 Bn | 2.75 Bn | 131.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 36.54 Mn |
| Sep 30, 2021 | 30.98 Mn |
| Dec 31, 2020 | 28.00 Mn |